Feasibility of Peripheral Angioplasty in Type D TASCII Lesions
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01297387|
Recruitment Status : Completed
First Posted : February 16, 2011
Last Update Posted : February 21, 2011
This observational prospective study will evaluate, according o usual local clinical practice, feasibility of endoluminal revascularization in diabetic patients with type C and D lesions, according to TASC II Criteria.
About 300 patients will be treated with usual revascularization procedure. Each patient will be followed at least 12 months to evaluate clinical outcome and limb salvage interventions.
|Condition or disease||Intervention/treatment|
|Diabetes Critical Limb Ischemia||Other: PTA BPG procedure,|
|Study Type :||Observational|
|Actual Enrollment :||344 participants|
|Official Title:||An Observational, Prospective Study Evaluating Feasibility of Peripheral Angioplasty in Diabetic Patients With Critical Limb Ischemia in C and D Obstructions of Transatlantic Inter-Society Consensus (TASC II).|
|Study Start Date :||January 2009|
|Actual Study Completion Date :||December 2009|
Revascularization of limb ischemia
Other: PTA BPG procedure,
Surgery PTA or BPG Procedure, according usual local clinical practice
Other Name: Peripheral angioplasty
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01297387
|Diabetic Foot Center IRCCS MultiMedica|
|Sesto San Giovanni, Milano, Italy, 20099|
|Principal Investigator:||Ezio Faglia, MD||Diabetic Foot Centre IRCCS MultiMedica|